Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge.

Autor: Altunkaya J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK. Electronic address: james.altunkaya@ndph.ox.ac.uk., Li X; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Adler A; Diabetes Trial Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, England, UK., Feenstra T; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Fridhammar A; The Swedish Institute for Health Economics, Lund, Sweden., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Lamotte M; IQVIA, Zaventem, Belgium; Th(is)(2)Modeling, Asse, Belgium., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, Wales, UK., Nilsson A; IQVIA, Zaventem, Belgium., Palmer AJ; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania, Australia., Quan J; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong., Smolen H; Medical Decision Modeling Inc, Indianapolis, IN, USA., Tran-Duy A; Centre for Health Policy, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, VIC, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia., Valentine W; Ossian Health Economics and Communications, Basel, Switzerland., Willis M; The Swedish Institute for Health Economics, Lund, Sweden., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Clarke P; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct; Vol. 27 (10), pp. 1338-1347. Date of Electronic Publication: 2024 Jul 08.

Decrements in health‐related quality of life associated with adverse events in people with diabetes

Autor: Keng, MJ, Leal, J, Bowman, L, Armitage, J, Mihaylova, B

Publikováno v: Diabetes, Obesity and Metabolism. 24:530-538

Aim People with diabetes are at elevated risk of adverse events due to the disease and treatments. We estimate the decrements in health-related quality of life (QoL) associated with a range of adverse events. This will inform assessments of the effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb32dd25b0f5d85694e09e8d6b5347b6
https://doi.org/10.1111/dom.14610

Developing a framework for modelling outcomes in diabetes - A case study with ASCEND

Autor: Keng, MJ

Decision-analytic modelling is used to synthesise clinical and economic data to evaluate health outcomes and costs of novel healthcare interventions. Diabetes is associated with disabling and costly complications which develop over time, and such mod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9422d9a80268110204a9128ec5056d40

Hospital costs associated with adverse events in people with diabetes in the UK.

Autor: Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; British Heart Foundation Centre of Research Excellence, Oxford, UK., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Bowman L; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Armitage J; British Heart Foundation Centre of Research Excellence, Oxford, UK.; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Mihaylova B; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Nov; Vol. 24 (11), pp. 2108-2117. Date of Electronic Publication: 2022 Jun 29.

Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.

Autor: Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK; British Heart Foundation Centre of Research Excellence, Oxford, England, UK. Electronic address: mijun.keng@ndph.ox.ac.uk., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK., Mafham M; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK., Bowman L; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK., Armitage J; British Heart Foundation Centre of Research Excellence, Oxford, England, UK; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK., Mihaylova B; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, England, UK; Wolfson Institute of Population Health, Queen Mary University of London, London, England, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Mar; Vol. 25 (3), pp. 435-442. Date of Electronic Publication: 2021 Oct 27.